Zydus Lifesciences [ZYDUSLIFE] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Zydus Lifesciences

NSE
Loading...

Torrent

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zydus Lifesciences wins in 10 metrics, Torrent wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricZydus LifesciencesTorrentBetter
P/E Ratio (TTM)21.8160.35Zydus Lifesciences
Price-to-Book Ratio4.1615.90Zydus Lifesciences
Debt-to-Equity Ratio12.2142.81Zydus Lifesciences
PEG Ratio6.553.04Torrent
EV/EBITDA14.7332.45Zydus Lifesciences
Profit Margin (TTM)19.37%16.92%Zydus Lifesciences
Operating Margin (TTM)27.28%26.15%Zydus Lifesciences
EBITDA Margin (TTM)27.28%26.15%Zydus Lifesciences
Return on Equity17.17%25.18%Torrent
Return on Assets (TTM)12.16%12.75%Torrent
Free Cash Flow (TTM)$50.64B$19.73BZydus Lifesciences
Dividend Yield1.44%17.47%Torrent
1-Year Return-7.14%1.18%Torrent
Price-to-Sales Ratio (TTM)4.2310.20Zydus Lifesciences
Enterprise Value$997.19B$1,232.89BTorrent
EV/Revenue Ratio4.2210.42Zydus Lifesciences
Gross Profit Margin (TTM)72.33%75.26%Torrent
Revenue per Share (TTM)$235$350Torrent
Earnings per Share (Diluted)$45.44$59.11Torrent
Beta (Stock Volatility)0.470.13Torrent
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Zydus Lifesciences vs Torrent Stock Performance Analysis

Loading Price Chart...

Zydus Lifesciences
Torrent
Zydus Lifesciences Stock Overview | Torrent Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zydus Lifesciences-1.03%-6.02%-0.92%-0.81%11.90%0.83%
Torrent-1.47%-1.30%-2.55%5.42%8.22%2.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zydus Lifesciences-7.14%132.68%124.18%140.63%615.25%2,933.36%
Torrent1.18%123.52%25.54%130.19%1,120.04%4,445.07%

News Based Sentiment: Zydus Lifesciences vs Torrent

Zydus Lifesciences

News based Sentiment: MIXED

September presented a mixed bag for Zydus Lifesciences. While the company demonstrated strong financial performance in Q1 FY26 and received a positive FDA upgrade, the share price experienced a decline due to US tariff announcements. This combination of positive and negative developments creates a 'mixed' investment narrative.

View Zydus Lifesciences News Sentiment Analysis

Torrent

News based Sentiment: POSITIVE

Torrent Pharmaceuticals reported strong financial results for both FY24-25 and Q1 FY2025-26, demonstrating consistent growth in revenue and profit. Positive analyst ratings and a commitment to CSR further strengthen the investment case, indicating a positive trajectory for the company.

View Torrent News Sentiment Analysis

Performance & Financial Health Analysis: Zydus Lifesciences vs Torrent

MetricZYDUSLIFETORNTPHARM
Market Information
Market Cap i₹998.40B₹1.24T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,002,098356,705
90 Day Avg. Volume i1,051,582234,368
Last Close₹981.90₹3,514.70
52 Week Range₹795.00 - ₹1,088.85₹2,886.45 - ₹3,787.90
% from 52W High-9.82%-7.21%
All-Time High₹1,324.30 (Aug 05, 2024)₹3,787.90 (Jul 30, 2025)
% from All-Time High-25.86%-7.21%
Growth Metrics
Quarterly Revenue Growth0.06%0.11%
Quarterly Earnings Growth0.03%0.20%
Financial Health
Profit Margin (TTM) i0.19%0.17%
Operating Margin (TTM) i0.27%0.26%
Return on Equity (TTM) i0.17%0.25%
Debt to Equity (MRQ) i12.2142.81
Cash & Liquidity
Book Value per Share (MRQ)₹238.05₹224.28
Cash per Share (MRQ)₹56.02₹20.33
Operating Cash Flow (TTM) i₹76.54B₹27.02B
Levered Free Cash Flow (TTM) i₹45.26B₹19.11B
Dividends
Last 12-Month Dividend Yield i1.44%17.47%
Last 12-Month Dividend i₹14.00₹552.76

Valuation & Enterprise Metrics Analysis: Zydus Lifesciences vs Torrent

MetricZYDUSLIFETORNTPHARM
Price Ratios
P/E Ratio (TTM) i21.8160.35
Forward P/E i24.1139.88
PEG Ratio i6.553.04
Price to Sales (TTM) i4.2310.20
Price to Book (MRQ) i4.1615.90
Market Capitalization
Market Capitalization i₹998.40B₹1.24T
Enterprise Value i₹997.19B₹1.23T
Enterprise Value Metrics
Enterprise to Revenue i4.2210.42
Enterprise to EBITDA i14.7332.45
Risk & Other Metrics
Beta i0.470.13
Book Value per Share (MRQ) i₹238.05₹224.28

Financial Statements Comparison: Zydus Lifesciences vs Torrent

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ZYDUSLIFETORNTPHARM
Revenue/Sales i₹64.67B₹31.28B
Cost of Goods Sold i₹17.90B₹7.74B
Gross Profit i₹46.78B₹23.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹17.93B₹8.31B
EBITDA i₹22.43B₹9.95B
Pre-Tax Income i₹19.21B₹7.38B
Income Tax i₹4.34B₹1.90B
Net Income (Profit) i₹15.21B₹5.48B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ZYDUSLIFETORNTPHARM
Cash & Equivalents i₹8.27B₹5.73B
Total Current Assets i₹170.46B₹56.23B
Total Current Liabilities i₹90.42B₹47.17B
Long-Term Debt i₹321.00M₹13.38B
Total Shareholders Equity i₹263.58B₹75.91B
Retained Earnings i₹245.62BN/A
Property, Plant & Equipment i₹60.42B₹2.99B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ZYDUSLIFETORNTPHARM
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricZYDUSLIFETORNTPHARM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,002,098356,705
Average Daily Volume (90 Day) i1,051,582234,368
Shares Outstanding i1.01B338.45M
Float Shares i248.90M103.96M
% Held by Insiders i0.75%0.71%
% Held by Institutions i0.14%0.15%

Dividend Analysis & Yield Comparison: Zydus Lifesciences vs Torrent

MetricZYDUSLIFETORNTPHARM
Last 12-Month Dividend i₹14.00₹552.76
Last 12-Month Dividend Yield i1.44%17.47%
3-Year Avg Annual Dividend i₹9.50₹198.92
3-Year Avg Dividend Yield i0.79%3.27%
3-Year Total Dividends i₹28.50₹596.76
Ex-Dividend DateJul 25, 2025Jun 20, 2025